MYC and leukemia: In addition, OA2-siRAPSYN could significantly inhibit the proliferation of Ph+ leukemia cell lines, through the regulation of Wnt/β-catenin/c-Myc signaling pathway, which is another advantage to possibly eliminate leukemia stem cells in Ph+ leukemia patients [33–35].